内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

PULSE BIOSCIENCES, INC.

PLSE · Nasdaq · CIK 0001625101 · Healthcare · Medical Instruments & Supplies

内部人信号

72.6 / 100

3 位买方 · 8 条买入交易行 · $26.8M 买入总额

为什么有这个信号？

买方广度中等
买入规模较强
角色中等
近期性中等
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+21.0 / 35
买入规模+24.0 / 25
角色+13.0 / 20
近期性+4.6 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
  • ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Teplitsky Liane RaeChief Operating Officer
●●●●
DUGGAN ROBERT WDirector,TenPercentOwner
●●
LAVIOLETTE PAUL AChief Executive Officer
●●
● 买入▼ 卖出○ 其他

—

买方广度与集中度

合资格买方3
买入集中度97%最大买方： DUGGAN ROBERT W · $26.0M
聚集买入 · 15天2 insiders峰值活动： 2026-05-11–2026-05-11

Roles in the peak window: Chief Executive Officer, Director,TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

72.6 / 100

最新留档分数

↓ -0.2 pts相对上一个留档快照
  1. 73.0
  2. 73.0
  3. 72.8
  4. 72.8
  5. 72.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

8买入
7卖出
7其他 Form 4 交易行
9SEC 申报 · 365天
买入8 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他0 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-1.1%
3M
+107.8%
6M
+188.2%
12M
+169.9%

波动率与流动性

波动率
78.2%
Beta
—
平均每日成交额
USD 27.4M

估值

市值
USD 3.8B
P/E
—

基本面

利润率
—
ROE
-90.2%
细分行业
Medical Instruments & Supplies

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-31 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
3,312,487
上期报告
3,139,674
日均成交量
590,533
回补天数
5.6

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-09-01Teplitsky Liane Rae买入 (P)Common Stock1,001USD 49.95USD 50,000SEC 申报 ↗
2026-08-31Teplitsky Liane Rae买入 (P)Common Stock1,024USD 48.80USD 49,971SEC 申报 ↗
2026-08-28Teplitsky Liane Rae买入 (P)Common Stock1,034USD 48.35USD 49,994SEC 申报 ↗
2026-08-26Teplitsky Liane Rae买入 (P)Common Stock1,036USD 48.24USD 49,977SEC 申报 ↗
2026-05-11DUGGAN ROBERT W买入 (P)Common Stock660,233USD 19.69USD 12,999,988SEC 申报 ↗
2026-05-11LAVIOLETTE PAUL A买入 (P)Common Stock15,000USD 19.69USD 295,350SEC 申报 ↗
2026-05-11LAVIOLETTE PAUL A买入 (P)Common Stock15,000USD 19.69USD 295,350SEC 申报 ↗
2026-05-11DUGGAN ROBERT W买入 (P)Common Stock660,233USD 19.69USD 12,999,988SEC 申报 ↗
2025-09-10DUGGAN ROBERT W买入 (P)Common Stock34,659USD 14.66USD 508,101SEC 申报 ↗
2024-12-13DUGGAN ROBERT W买入 (P)Common Stock55,256USD 17.18USD 949,298SEC 申报 ↗
2024-12-12DUGGAN ROBERT W买入 (P)Common Stock45,404USD 17.13USD 777,771SEC 申报 ↗
2024-12-11DUGGAN ROBERT W买入 (P)Common Stock56,054USD 17.35USD 972,344SEC 申报 ↗
2024-09-12DUGGAN ROBERT W买入 (P)Common Stock145,140USD 14.41USD 2,091,467SEC 申报 ↗
2024-09-11DUGGAN ROBERT W买入 (P)Common Stock12,800USD 14.77USD 189,056SEC 申报 ↗
2024-05-20Barrett Burke Thomas买入 (P)Common Stock10,000USD 8.56USD 85,600SEC 申报 ↗

Form 4 申报证据

22 transaction lines in the latest 365-day window; 156 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-01Teplitsky Liane Rae买入 (P)Common Stock1,001USD 49.95USD 50,000SEC 申报 ↗
2026-08-31Teplitsky Liane Rae买入 (P)Common Stock1,024USD 48.80USD 49,971SEC 申报 ↗
2026-08-28Teplitsky Liane Rae买入 (P)Common Stock1,034USD 48.35USD 49,994SEC 申报 ↗
展开近期 Form 4 证据 (22 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-01Teplitsky Liane Rae买入 (P)Common Stock1,001USD 49.95USD 50,000SEC 申报 ↗
2026-08-31Teplitsky Liane Rae买入 (P)Common Stock1,024USD 48.80USD 49,971SEC 申报 ↗
2026-08-28Teplitsky Liane Rae买入 (P)Common Stock1,034USD 48.35USD 49,994SEC 申报 ↗
2026-08-26Teplitsky Liane Rae买入 (P)Common Stock1,036USD 48.24USD 49,977SEC 申报 ↗
2026-05-11DUGGAN ROBERT W买入 (P)Common Stock660,233USD 19.69USD 12,999,988SEC 申报 ↗
2026-05-11LAVIOLETTE PAUL A买入 (P)Common Stock15,000USD 19.69USD 295,350SEC 申报 ↗
2026-05-11LAVIOLETTE PAUL A买入 (P)Common Stock15,000USD 19.69USD 295,350SEC 申报 ↗
2026-05-11DUGGAN ROBERT W买入 (P)Common Stock660,233USD 19.69USD 12,999,988SEC 申报 ↗
2026-02-18Danahy Kevin Patrick卖出 (S)Common Stock5,000USD 23.64USD 118,200SEC 申报 ↗
2026-02-18Danahy Kevin Patrick期权行权／转换 (M)Common Stock5,000USD 1.53USD 7,650SEC 申报 ↗
2026-02-17Danahy Kevin Patrick卖出 (S)Common Stock20,000USD 23.63USD 472,600SEC 申报 ↗
2026-02-17Danahy Kevin Patrick期权行权／转换 (M)Common Stock20,000USD 1.53USD 30,600SEC 申报 ↗
2026-02-13Danahy Kevin Patrick卖出 (S)Common Stock20,000USD 23.53USD 470,600SEC 申报 ↗
2026-02-13Danahy Kevin Patrick期权行权／转换 (M)Common Stock20,000USD 1.53USD 30,600SEC 申报 ↗
2026-02-12Danahy Kevin Patrick卖出 (S)Common Stock20,000USD 23.37USD 467,400SEC 申报 ↗
2026-02-12Danahy Kevin Patrick期权行权／转换 (M)Common Stock20,000USD 1.53USD 30,600SEC 申报 ↗
2026-02-11Danahy Kevin Patrick卖出 (S)Common Stock20,000USD 25.20USD 504,000SEC 申报 ↗
2026-02-11Danahy Kevin Patrick期权行权／转换 (M)Common Stock20,000USD 1.53USD 30,600SEC 申报 ↗
2026-02-10Danahy Kevin Patrick卖出 (S)Common Stock20,000USD 23.52USD 470,400SEC 申报 ↗
2026-02-10Danahy Kevin Patrick期权行权／转换 (M)Common Stock20,000USD 1.53USD 30,600SEC 申报 ↗
2026-02-09Danahy Kevin Patrick卖出 (S)Common Stock20,000USD 21.45USD 429,000SEC 申报 ↗
2026-02-09Danahy Kevin Patrick期权行权／转换 (M)Common Stock20,000USD 1.53USD 30,600SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码PLSE
CIK0001625101
行业Healthcare
细分行业Medical Instruments & Supplies Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
交易所Nasdaq

数据覆盖

本地 Form 4 历史156 transaction lines from 2020-06-15 to 2026-09-01
54 P purchase lines · 18 S sale lines · 84 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.